The Aperlena Verdict
Open raceNo supplier dominates: 254 different companies have won the last 661 comparable contracts from this buyer over 5 years. This is a genuinely open race.
- Expected final price vs the published estimate
- 0%
Based on 661 comparable awards by this buyer in this sector over 5 years. Every verdict is recorded before the outcome and graded against the award notice. How we score ourselves.
Summary
Machine-generated summaryThis tender concerns the purchase of a combined antiretroviral medicine in tablet form. The product to be supplied contains three active substances in a single tablet: efavirenz 600 mg, emtricitabine 200 mg and tenofovir 245 mg. This fixed-dose combination is used in the treatment of HIV infection, so the contract covers the supply of these tablets to the contracting authority for use in patient care. The notice provides only the title of the procurement, identifying the reference number CPU No. 181A000008 and the product to be acquired, without further descriptive detail.
Official source
Source: BASE - Portal dos Contratos Públicos (IMPIC)
Always verify details on the official notice.
Last verified against BASE - Portal dos Contratos Públicos (IMPIC) 3 days ago
More from this buyer
Full buyer profile127 open tenders right now
- 261A000117 - CITRATO 4% SOLUÇÃO ANTICOAGULANTE 1 day left
- 261A000116 - Reagentes 2 days left
- Consumable medical devices - 262A000195 - Acquisition of Medical Devices for Traumatology (encavilhamento), 2026 and 2027 2 days left
Who usually wins this buyer's contracts in this sector
| Company | Wins | Total awarded | Last win |
|---|---|---|---|
| GENERIS FARMACÊUTICA S.A | 17 | €146,661 | Sep 2026 |
| ACCORD HEALTHCARE UNIPESSOAL LDA | 16 | €363,988 | Aug 2026 |
| FRESENIUS KABI PHARMA PORTUGAL, LDA. | 16 | €313,366 | Sep 2026 |
| GENERIS - FARMACEUTICA, S.A. | 15 | €357,803 | Sep 2026 |
| XPHARMA, Lda. | 14 | €51,218 | Sep 2026 |
Based on 661 awards with a linked company profile over the last 5 years.
What this buyer has paid before
Based on 666 comparable contracts this buyer awarded in this sector over the last 4 years.
- Lower quartile
- €1,443
- Median award
- €6,981
- Upper quartile
- €28,460
This tender is estimated 1533% above that median
Most recent awards
- 261Y000617/13559 - IMIPENEM 500 MG + CILASTATINA 5 €102,563
- 261G001039/13559 - AC MONOCLONAL ANTI CD123-APC €810
- 261Y000618/13559 - BRIGAtinib 30 MG COMP €2,212
- 261G001021/13559 - VÁRIOS REAGENTES €810
- 261X000268 - CANABIDIOL 100MG/ML SOL ORAL FRS 100ML €17,765
Award values as published by the official sources. Use them as a guide, not a rule: scope, lots and duration differ between contracts.
Similar tenders
Market context
- Avg. open tender · Medical equipment & pharmaceuticals
- €11,266,127
- Buyer track record on Aperlena
- 2,796 notices tracked · 993 awarded
- €42,155,045 in awarded contracts
Never miss a tender like this
1,153 new notices in Medical equipment & pharmaceuticals in Portugal in the last 7 days. Get an email when new ones appear. Free.
Set up my alert